Recursion Pharmaceuticals (RXRX.MX) Q4 2025 Earnings

5NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-10.88
-9.46
-8.04
-6.62

Details

Expected EPS
-7.0113900844
Actual EPS
-6.692688
Surprise EPS
0.32
Surprise Percent
+4.55%

Description

Recursion Pharmaceuticals (RXRX.MX) has reported earnings of -6.692688 per share for Q4 2025.

0 Comments

Share your thoughts